PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17683829-6	2007	We further tested whether the intraperitoneal injection of IL-1beta, known to aggravate the ibotenate-induced lesions, could modify the expression pattern of VIP-related genes.	Ibotenic Acid	92-101	interleukin 1 beta	Homo sapiens	59-67	
20221418-11	2009	Excitotoxic lesions of the rostral ventromedial medulla with ibotenic acid (2 mug) abolished IL-1beta-induced contralateral hyperalgesia, suggesting a contribution of descending facilitatory drive.	Ibotenic Acid	61-74	interleukin 1 beta	Homo sapiens	93-101	
17683829-7	2007	Finally, we concluded using histological analysis that VIP[ala(11,22,28)], a synthetic VPAC(1) agonist completely reversed the aggravating effects of IL-1beta on ibotenate-induced lesions of the periventricular white matter.	Ibotenic Acid	162-171	interleukin 1 beta	Homo sapiens	150-158	
14595770-5	2003	Unilateral ibotenic acid lesions encompassing the ventral BNST significantly reduced both IL-1beta-induced increases in Fos immunoreactivity in corticotropin-releasing factor (CRF) cells of the hypothalamic paraventricular nucleus (PVN) and corresponding increases in adrenocorticotropic hormone (ACTH) secretion.	Ibotenic Acid	11-24	interleukin 1 beta	Homo sapiens	90-98	
12676149-5	2003	We found that ibotenic acid lesions of the PVN significantly reduced numbers of Fos-positive non-catecholamine, noradrenergic and adrenergic cells observable in the VLM and NTS after interleukin-1beta administration.	Ibotenic Acid	14-27	interleukin 1 beta	Homo sapiens	183-200